S11 Ep45: Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD
OncLive® On Air
00:00
Ponatinib Preventing BCR-ABL Mutations
Discussion about OPTIC finding that ponatinib may prevent emergence of BCR-ABL mutations and need for further research.
Play episode from 08:00
Transcript
